Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Psychological resilience predicts medication adherence in multiple sclerosis.
Multivariate age-related variations in quantitative MRI maps: widespread age-related differences revisited.
Growth Differentiation Factor 11 Is a Circulating Regulator of Oligodendrocyte Differentiation and CNS Myelin Formation and Repair.
Epstein-Barr virus and multiple sclerosis: Mechanisms, therapeutic implications, and emerging interventions.
N4-Acetyl-Sulfamethoxazole Bladder Stones Caused by Trimethoprim-Sulfamethoxazole Prophylaxis: A Report of Two Cases.
Cuprizone-induced demyelination model mice exhibit antisocial maltreating behavior: an experimental animal study.
Sex-stratified blood transcriptomic candidate biomarkers of multiple sclerosis identified by ensemble feature selection.
Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.
[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].
A novel homozygous variant in the POLR1A gene: a complicated hereditary spastic paraplegia (c-HSP) or a hypomyelinating leukodystrophy type-27 (HLD27) phenotype?
Comparison of Proteomic Analysis of Cerebrospinal Fluid From Neurological Patients With and Without Amyotrophic Lateral Sclerosis.
Sex-dependent protective effects of microglial tumor necrosis factor on post-stroke inflammation and myelin injury.
Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study.
Recombinant rat heat shock protein 70 (rrHSP70) may promote remyelination by regulating microglia/macrophages and oligodendrocytes in a toxin-induced demyelination animal model.
Personalised Anti-CD20 Retreatment in Multiple Sclerosis: Precision Medicine or Precision Pharmacology?
: proposal for a neuroimmune role linking infection, stress, chronic disorders and the activity of kynurenic acid.
Common Inflammatory Pathways Between Periodontal Disease and Multiple Sclerosis: A Systematic Review.
High prevalence of low arousal threshold endotype in obstructive sleep apnea with multiple sclerosis.
Impaired auditory sensory gating as a neurophysiological correlate of cognitive fatigue in long COVID.
The Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Post-Diagnosis: Results from an International Survey.
Serum amylin levels in patients with multiple sclerosis: A cross-sectional case-control study.
Aegle marmelos neuroprotective potential in demyelination rat model through modulation of BDNF, GDNF, HSP-90 and HSP-60.
The Therapeutic Potential of Purmorphamine Across Disease Models.
Astrocyte-microglia lactate shuttle restrains microglial phenotypic transition during myelin phagocytosis in radiation-induced brain injury.
Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.
Pages
« first
‹ previous
…
1094
1095
1096
1097
1098
1099
1100
1101
1102
…
next ›
last »